Osteoporosis Awareness in Rheumatoid Arthritis Patients

Rheumatoid Arthritis Clinical Trial

Official title:

Knowledge and Awareness of Osteoporosis in Rheumatoid Arthritis Patients

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT05740085
• Other study ID #: OPRA1
• Status: Not yet recruiting
• Start date: April 30, 2023
• Est. completion date: August 30, 2023

Study information

• Verified date: February 2023
• Source: Uskudar State Hospital
• Contact: Mustafa H Temel, M.D.
• Phone: 05342714872
• Email: mhuseyintemel[@]gmail.com
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

Osteoporosis is a condition that describes compromised skeletal microarchitecture in general, with clinical signs of decreased bone mineral density. Rheumatoid arthritis patients are at increased risk for developing osteoporosis. It is crucial to identify whether rheumatoid arthritis patients know and know about this disease. This study investigates awareness and knowledge of osteoporosis in rheumatoid arthritis patients.

Description:

Osteoporosis is a common disease of bone loss. The reduced bone strength predisposes an increased risk for fractures in older individuals. It can affect people from different ethnicity. Many factors increase the risk of osteoporosis, including age, postmenopausal state, glucocorticoid use, low body weight, calcium, vitamin D, immobility, and chronic inflammation. Patients with rheumatoid arthritis are at high risk of developing osteoporosis due to chronic inflammation and the medications they use. Patients' knowledge and awareness about osteoporosis are essential for early detection, implementation of lifestyle changes, and treatment compliance. This study aimed to investigate osteoporosis awareness and knowledge about osteoporosis in patients with rheumatoid arthritis.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 100
• Est. completion date: August 30, 2023
• Est. primary completion date: July 30, 2023
• Gender: All
• Age group: 18 Years to 90 Years

Eligibility

Inclusion Criteria:

• Clinical diagnosis of rheumatoid arthritis

• Must be between the ages of 18 and 90

• Must give consent to participate in the study

Exclusion Criteria:

• Not giving consent

Related Conditions & MeSH terms

• Arthritis
• Arthritis, Rheumatoid
• Osteoporosis
• Rheumatoid Arthritis

Intervention

Other:
• Patient information form
Patients will be asked to fill out a patient information form and an osteoporosis awareness form

Locations

Country	Name	City	State
Turkey	Üsküdar State Hospital	Istanbul	Üsküdar

Sponsors (1)

Lead Sponsor	Collaborator
Uskudar State Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Level of knowledge in osteoporosis	Level of knowledge in osteoporosis will be assessed with revised osteoporosis knowledge test (OKT). The Revised OKT (2012) is a comprehensive instrument reflecting current research and assesses osteoporosis knowledge of adults. Responses offered to participants are multiple choice (e.g., for risk items: more likely, less likely, neutral, don't know), there is only one correct answer for each item. Responses are dichotomously recoded as correct or incorrect. In a U.S. sample of adults, the measure demonstrated internal consistency, very good stability, and content validity. Point-biserial correlations supported the measure's validity.	1 day